The global adaptogens market revenue was around US$ 11.8 billion in 2023 and is estimated to reach US$ 22.3 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2024 to 2032.
Adaptogens are mushrooms and plants that aid a person's body respond to anxiety, fatigue, and overall well-being. Individuals can take adaptogens by adding them to beverages or food in the form of tea or take them as capsules. Adaptogens bring a person’s body back to a steady balance by handling both physical and mental stressors.
Market Driving Factors
The surge in product demand from the pharmaceutical sector due to the application of adaptogens in medicinal products is estimated to boost market growth. This is because an extensive number of individuals who struggle with high levels of anxiety and stress need a solution, and adaptogens can be a revolutionary pharmacological treatment for tension. This is owing to their numerous benefits in alleviating stress without side effects. Additionally, a significant number of consumers are abandoning medical and pharmaceutical products because they do not offer the intended results. This has led to a surge in the usage of adaptogens in the pharmaceutical industry to treat cardiovascular, and digestive disorders. This factor is estimated to propel the market growth.
The cosmetics industry has grown globally, resulting in an increasing demand for adaptogens to improve appearance and attractiveness, which is estimated to drive the product demand. Additionally, 'clean beauty' and 'green beauty' are facilitating cosmetic scientists to design novel formulas utilizing conventional and regional constituents such as adaptogens. Furthermore, manufacturers of beauty and cosmetics products are shifting away from different cosmetic chemicals and toward natural ingredients, such as herbs and natural antioxidants such as adaptogens, and Rhodiola rosea, as these products have no negative side effects. Such factors are estimated to boost the market growth.
Regional Analysis
Asia-Pacific is estimated to dominate the market in terms of the largest. shares. The increasing demand for adaptogens in beverages can be due to their ability to encourage mental well-being and help reduce the effects of stress on the human body. The surge in the health consciousness among customers along with high demand for healthy beverages is predicted to boost the product demand. Additionally, increasing consumer interest in exploring new food & beverages capable of offering a calming sensation, and propelling immunity and energy is expected to drive the market growth in the region.
Segmentation Insights
Source Insight
The ashwagandha segment is predicted to dominate the market in terms of the largest shares. This is owing to the increasing consumer demand for supplements with improved nutrition and enhanced functional advantages increase the demand for ashwagandha. Furthermore, ashwagandha finds profitable applications in sports nutrition due to its ability to enhance endurance, and muscle strength, decrease body fat, and post-workout muscle injury. Thus, the surging application of ashwagandha in the pharmaceutical industry is estimated to propel the market growth.
End Use Insight
The powder segment dominates the market in terms of the fastest growth. This is because it provides the benefit of easy blending with different liquids including water, milk, and coffee. The powder form of adaptogens such as ginseng and medicinal mushrooms are broadly utilized in commercial food products and are easy to utilize. The powder-based end-use product provides the benefit of an easy blend with different liquids including water and coffee which is propelling the market expansion.
Application Insight
The food & beverage segment is predicted to dominate the market in terms of the major shares. This is owing to the concept of superfoods acquiring prominence in most nations, as a greater number of people are undergoing stress owing to their hectic lifestyles. As a result, such lifestyle conditions of people are increasing the demand for adaptogens in the food and beverage market. Furthermore, with the surge in awareness about health advantages associated with adaptogens, their application in the food & beverages industry is growing. Adaptogen-based food products provide various advantages such as they relieve stress and are rich in antioxidants that improve immunity which will boost the market growth.
Prominent Companies
Segmentation Outline
The global adaptogens market segmentation focuses on the Source, End Use, Application, Distribution Channel, and Region.
By Source
By End Use
By Application
By Distribution Channel
By Region
[ TABLE OF CONTENT ]
1 INTRODUCTION OF GLOBAL ADAPTOGENS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: ADAPTOGENS MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL ADAPTOGENS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL ADAPTOGENS MARKET, BY SOURCE
5.1 OVERVIEW
5.2 ASHWAGANDHA
5.3 GINSENG
5.4 ASTRAGALUS
5.5 HOLY BASILS
5.6 RHODIOLA ROSEAS
5.7 SCHISANDRA
5.8 ADAPTOGENIC MUSHROOMS
5.9 OTHERS
6 GLOBAL ADAPTOGENS MARKET, BY END USE
6.1 OVERVIEW
6.2 POWDER
6.3 CAPSULES
6.4 TEAS AND BEVERAGES
6.5 OTHERS
7 GLOBAL ADAPTOGENS MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 FOOD AND BEVERAGES
7.3 DIETARY AND SPORTS SUPPLEMENTS
7.4 COSMETICS
7.5 ANIMAL FEED
7.6 PHARMACEUTICAL
8 GLOBAL ADAPTOGENS MARKET, BY DISTRIBUTION CHANNEL
8.1 OVERVIEW
8.2 BUSINESS TO BUSINESS
8.3 BUSINESS TO CONSUMER
8.3.1 SALES CHANNEL
8.3.1.1 SUPERMARKET AND HYPERMARKET
8.3.1.2 SPECIALTY STORE
8.3.1.3 PHARMACIES AND DRUG STORES
8.3.1.4 OTHERS
9 GLOBAL ADAPTOGENS MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA MARKET SNAPSHOT
9.2.2 U.S.
9.2.3 CANADA
9.2.4 MEXICO
9.3 EUROPE
9.3.1 EUROPE MARKET SNAPSHOT
9.3.2 WESTERN EUROPE
9.3.2.1 THE UK
9.3.2.2 GERMANY
9.3.2.3 FRANCE
9.3.2.4 ITALY
9.3.2.5 SPAIN
9.3.2.6 REST OF WESTERN EUROPE
9.3.3 EASTERN EUROPE
9.3.3.1 POLAND
9.3.3.2 RUSSIA
9.3.3.3 REST OF EASTERN EUROPE
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC MARKET SNAPSHOT
9.4.2 CHINA
9.4.3 JAPAN
9.4.4 INDIA
9.4.5 AUSTRALIA & NEW ZEALAND
9.4.6 ASEAN
9.4.7 REST OF ASIA PACIFIC
9.5 MIDDLE EAST & AFRICA
9.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
9.5.2 UAE
9.5.3 SAUDI ARABIA
9.5.4 SOUTH AFRICA
9.5.5 REST OF MEA
9.6 SOUTH AMERICA
9.6.1 SOUTH AMERICA MARKET SNAPSHOT
9.6.2 BRAZIL
9.6.3 ARGENTINA
9.6.4 REST OF SOUTH AMERICA
10 GLOBAL ADAPTOGENS MARKET COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPANY MARKET RANKING
10.3 KEY DEVELOPMENT STRATEGIES
10.4 COMPETITIVE DASHBOARD
10.5 PRODUCT MAPPING
10.6 TOP PLAYER POSITIONING, 2022
10.7 COMPETITIVE HEATMAP
10.8 TOP WINNING STRATEGIES
11 COMPANY PROFILES
11.1 PLT HEALTH SOLUTIONS
11.1.1 OVERVIEW
11.1.2 FINANCIAL PERFORMANCE
11.1.3 PRODUCT OUTLOOK
11.1.4 KEY DEVELOPMENTS
11.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.2 RIAAN WELLNESS PVT LTD
11.2.1 OVERVIEW
11.2.2 FINANCIAL PERFORMANCE
11.2.3 PRODUCT OUTLOOK
11.2.4 KEY DEVELOPMENTS
11.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.3 DABUR INDIA LTD
11.3.1 OVERVIEW
11.3.2 FINANCIAL PERFORMANCE
11.3.3 PRODUCT OUTLOOK
11.3.4 KEY DEVELOPMENTS
11.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.4 EMAMI LIMITED
11.4.1 OVERVIEW
11.4.2 FINANCIAL PERFORMANCE
11.4.3 PRODUCT OUTLOOK
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.5 INDENA S.P.A.
11.5.1 OVERVIEW
11.5.2 FINANCIAL PERFORMANCE
11.5.3 PRODUCT OUTLOOK
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.6 PROCTER & GAMBLE
11.6.1 OVERVIEW
11.6.2 FINANCIAL PERFORMANCE
11.6.3 PRODUCT OUTLOOK
11.6.4 KEY DEVELOPMENTS
11.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.7 KAIRALI AYURVEDIC GROUP
11.7.1 OVERVIEW
11.7.2 FINANCIAL PERFORMANCE
11.7.3 PRODUCT OUTLOOK
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.8 SHREE BAIDYANATH AYURVEDA BHAWAN PVT LTD
11.8.1 OVERVIEW
11.8.2 FINANCIAL PERFORMANCE
11.8.3 PRODUCT OUTLOOK
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.9 ENOMARK BIOTECH
11.9.1 OVERVIEW
11.9.2 FINANCIAL PERFORMANCE
11.9.3 PRODUCT OUTLOOK
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.10 UNILEVER
11.10.1 OVERVIEW
11.10.2 FINANCIAL PERFORMANCE
11.10.3 PRODUCT OUTLOOK
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.11 COLGATE-PALMOLIVE COMPANY
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.12 SHAHNAZ AYURVEDA PVT LTD
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS
10.12.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.13 PATANJALI AYURVED LIMITED
10.13.1 OVERVIEW
10.13.2 FINANCIAL PERFORMANCE
10.13.3 PRODUCT OUTLOOK
10.13.4 KEY DEVELOPMENTS
10.13.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.14 HIMALAYA WELLNESS
10.14.1 OVERVIEW
10.14.2 FINANCIAL PERFORMANCE
10.14.3 PRODUCT OUTLOOK
10.14.4 KEY DEVELOPMENTS
10.14.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.15 GIVAUDAN INTERNATIONAL SA
10.15.1 OVERVIEW
10.15.2 FINANCIAL PERFORMANCE
10.15.3 PRODUCT OUTLOOK
10.15.4 KEY DEVELOPMENTS
10.15.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
著作権 ©2022 無断複写・転載を禁じます